These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 15352293)

  • 41. Safety and efficacy of oral terbinafine in the treatment of onychomycosis: analysis of the elderly subgroup in Improving Results in ONychomycosis-Concomitant Lamisil and Debridement (IRON-CLAD), an open-label, randomized trial.
    Tavakkol A; Fellman S; Kianifard F
    Am J Geriatr Pharmacother; 2006 Mar; 4(1):1-13. PubMed ID: 16730616
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Harmless foot fungus? Not true! Threat of erysipelas].
    Warpakowski A
    MMW Fortschr Med; 2005 Feb; 147(5):15. PubMed ID: 15766019
    [No Abstract]   [Full Text] [Related]  

  • 43. Successful treatment of proximal white subungual onychomycosis with oral terbinafine therapy.
    Aman S; Nadeem M; Haroon TS
    J Coll Physicians Surg Pak; 2008 Nov; 18(11):728-9. PubMed ID: 18983803
    [TBL] [Abstract][Full Text] [Related]  

  • 44. What causes toenail fungus and how can I get rid of it?
    Johns Hopkins Med Lett Health After 50; 2003 Sep; 15(7):8. PubMed ID: 14533595
    [No Abstract]   [Full Text] [Related]  

  • 45. Onychocryptosis as consequence of effective treatment of dermatophytic onychomycosis.
    Bonifaz A; Paredes V; Fierro L
    J Eur Acad Dermatol Venereol; 2007 May; 21(5):699-700. PubMed ID: 17447997
    [No Abstract]   [Full Text] [Related]  

  • 46. What is new in fungal pharmacotherapeutics?
    Routt ET; Jim SC; Zeichner JA; Kircik LH
    J Drugs Dermatol; 2014 Apr; 13(4):391-5; quiz 396. PubMed ID: 24719057
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tolnaftate in superficial fungus infections.
    Alban J
    Am J Dis Child; 1965 Dec; 110(6):624-7. PubMed ID: 5844107
    [No Abstract]   [Full Text] [Related]  

  • 48. Ethics and micromanaged care.
    Brodell RT
    Arch Dermatol; 1996 Sep; 132(9):1013-5. PubMed ID: 8795540
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical inquiries. Which oral antifungal is best for toenail onychomycosis?
    Hinojosa JR; Hitchcock K; Rodriguez JE
    J Fam Pract; 2007 Jul; 56(7):581-2. PubMed ID: 17605954
    [No Abstract]   [Full Text] [Related]  

  • 50. Pharmacologic review: a review of the literature of ketoconazole therapy in the treatment of tinea pedis and onychomycosis.
    Cacciaglia GB; Tenczar AJ; Kanat IO
    J Foot Surg; 1984; 23(5):420-3. PubMed ID: 6094646
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combined surgical and systemic treatment of onychomycosis.
    Dominguez-Cherit J; Teixeira F; Arenas R
    Br J Dermatol; 1999 Apr; 140(4):778-80. PubMed ID: 10233357
    [No Abstract]   [Full Text] [Related]  

  • 52. [On fungus and taste].
    Backhaus E
    Lakartidningen; 2012 Dec 19-2013 Jan 8; 109(51-52):2368. PubMed ID: 23367556
    [No Abstract]   [Full Text] [Related]  

  • 53. Fungicidal activity plus reservoir effect allow short treatment courses with terbinafine in tinea pedis.
    Schäfer-Korting M; Schoellmann C; Korting HC
    Skin Pharmacol Physiol; 2008; 21(4):203-10. PubMed ID: 18509254
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The modern approach to the treatment for onychomycosis of hands and feet in the outpatient setting].
    Gerasimchuk EV; Gerasimov VV; Molchanov BA
    Voen Med Zh; 2005 Nov; 326(11):44-5. PubMed ID: 16404907
    [No Abstract]   [Full Text] [Related]  

  • 55. Tinea pedis caused by Hendersonula toruloidea. A new problem in dermatology.
    Greer DL; Gutierrez MM
    J Am Acad Dermatol; 1987 May; 16(5 Pt 2):1111-5. PubMed ID: 2953766
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Usefulness and pharmacokinetic study of oral terbinafine for hyperkeratotic-type tinea pedis.
    Kikuchi I; Tanuma H; Morimoto K; Kawana S
    Mycoses; 2008 Nov; 51(6):523-31. PubMed ID: 18422915
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The oral antifungal patient.
    Joseph WS
    Clin Podiatr Med Surg; 2004 Oct; 21(4):591-604, vii. PubMed ID: 15450899
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Pharmacoeconomic approach to onychomycosis therapy].
    Glad'ko VV; Tarasenko GN
    Voen Med Zh; 2002 Jun; 323(6):54-5. PubMed ID: 12140994
    [No Abstract]   [Full Text] [Related]  

  • 59. Foot problems. What to do about toenail fungus.
    Harv Womens Health Watch; 2001 Dec; 9(5):6. PubMed ID: 11751100
    [No Abstract]   [Full Text] [Related]  

  • 60. Allergic contact dermatitis due to diethyl sebacate.
    Sasaki E; Hata M; Aramaki J; Honda M
    Contact Dermatitis; 1997 Mar; 36(3):172. PubMed ID: 9145279
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.